Literature DB >> 26435500

Ubiquitination-dependent degradation of p73 by the mitochondrial E3 ubiquitin ligase Hades.

Bumki Min1, Jiwon Ryu1, Seung-Wook Chi2, Gwan-Su Yi3.   

Abstract

p73 is a member of the p53 family of transcription factors which plays an essential role in tumor suppression. p73 is associated with the sensitivity of cancer cells to chemotherapy and the prognosis of many cancers. In this study, we showed the ubiquitination-dependent degradation of p73 by the mitochondrial E3 ubiquitin ligase Hades. First, the binding between p73 and Hades was identified by co-immunoprecipitation experiments, and it was found that the Hades RING-finger domain mediates the interaction with p73. Immunofluorescence analysis showed that p73 moves to the mitochondria and colocalizes with Hades during etoposide-induced apoptosis. By performing in vivo and in vitro ubiquitination assays, we observed that the Hades RING-finger domain promotes ubiquitination of p73. Finally, it was shown that SiRNA-mediated depletion of Hades stabilizes p73. Taken together, our results showed that Hades mediates the ubiquitination-dependent degradation of mitochondrial p73 under apoptotic conditions. These findings suggest that Hades-mediated p73 ubiquitination is a novel regulatory mechanism for the exonuclear function of p73.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hades; Mitochondria; RING-finger domain; Ubiquitination; p73

Mesh:

Substances:

Year:  2015        PMID: 26435500     DOI: 10.1016/j.bbrc.2015.09.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  The Arabidopsis E3 Ubiquitin Ligase SP1 Targets to Chloroplasts, Peroxisomes, and Mitochondria.

Authors:  Ronghui Pan; Jianping Hu
Journal:  Plant Physiol       Date:  2018-01       Impact factor: 8.340

2.  Cytoplasmic pro-apoptotic function of the tumor suppressor p73 is mediated through a modified mode of recognition of the anti-apoptotic regulator Bcl-XL.

Authors:  Mi-Kyung Yoon; Bu-Yeon Kim; Ji-Young Lee; Ji-Hyang Ha; Sung Ah Kim; Dong-Hwa Lee; Min-Sung Lee; Mi-Kyung Lee; Jin Sun Choi; Jin Hwa Cho; Jeong-Hoon Kim; Sunhong Kim; Jaewhan Song; Sung Goo Park; Byoung Chul Park; Kwang-Hee Bae; Sang Un Choi; Seung-Wook Chi
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

3.  Mitochondrial MUL1 E3 ubiquitin ligase regulates Hypoxia Inducible Factor (HIF-1α) and metabolic reprogramming by modulating the UBXN7 cofactor protein.

Authors:  Lucia Cilenti; Jacopo Di Gregorio; Camilla T Ambivero; Thomas Andl; Ronglih Liao; Antonis S Zervos
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.996

Review 4.  The emerging roles of E3 ubiquitin ligases in ovarian cancer chemoresistance.

Authors:  Yang Meng; Lei Qiu; Su Zhang; Junhong Han
Journal:  Cancer Drug Resist       Date:  2021-06-19

Review 5.  Regulation of the p53 Family Proteins by the Ubiquitin Proteasomal Pathway.

Authors:  Scott Bang; Sandeep Kaur; Manabu Kurokawa
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.